Alvotech shares weakened amid active trading as financial losses, regulatory execution, manufacturing demands, and biosimilar ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alvotech stock is coming off a difficult stretch, with the share price down about 64% over the past five years, yet the broader valuation checks currently lean toward the shares looking cheap on ...

From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites ...

Alvotech, the Icelandic holdout battling AbbVie in court over its Humira biosimilar, has reached an accord with the U.S. pharma giant. With a settlement in place, the companies are putting all patent ...

Alvotech, a global biotech company focused on developing biosimilar medicines, announced the acquisition of the Ivers-Lee Group, a Swiss family-owned business specializing in pharmaceutical assembly ...

Alvotech (NASDAQ:ALVO) shares saw a positive lift Wednesday morning following the announcement that the biosimilar developer has significantly bolstered its production capabilities by acquiring Swiss ...

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders ...

HYDERABAD, INDIA & REYKJAVIK, ICELAND (June 5, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide ...